CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Rhythm shares close higher on report of AstraZeneca $10 bln takeover offer

By Reuters News

** Shares of Rhythm Pharmaceuticals RYTM.O closed up 28% at $110.68 following a media report of a takeover bid from AstraZeneca AZN.L

** British drugmaker AstraZeneca recently made a roughly $10 billion takeover offer for Rhythm Pharmaceuticals, the Wall Street Journal reported, citing people familiar with the matter

** Shares of RYTM trade at $108.44 in extending trading

** AstraZeneca offered to pay $124 per share for the US-based biotech last month, according to the report

** AstraZeneca declined to comment, while Rhythm did not respond to a request for comment

** YTD, RYTM shares down 1.8%, while AZN shares up 1.92%

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk